Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 5NIH 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukoplakia, Oral 1Leukoplakia, Hairy 1HIV Infections 1Epstein-Barr Virus Infections 1AIDS-Related Opportunistic Infections 1AIDS-Related Complex 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Acyclovir × Clear all
NCT00002026 2005-06-24

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

NIH AIDS Clinical Trials Information Service

Phase NA Completed
Head & Neck

AIDS-Related Complex, Leukoplakia, Oral, HIV Infections, AIDS-Related Opportunistic Infections, Leukoplakia, Hairy, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡